Abonnement à la biblothèque: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publication de 6  numéros par an

ISSN Imprimer: 0743-4863

ISSN En ligne: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Antibody-Based Targeting of Angiogenesis

Volume 18, Numéro 3, 2001, 41 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i3.20
Get accessGet access

RÉSUMÉ

Angiogenesis—the sprouting of new blood vessels from pre-existing ones—is a characteristic feature of relevant diseases such as cancer, some blinding ocular disorders, rheumatoid arthritis, and psoriasis. This article reviews recent progress in the generation of monoclonal antibodies, which recognize and target new blood vessels in vivo, while sparing mature vessels and healthy tissues. The use of such antibodies as selective "molecular vehicles" is likely to open new important diagnostic and therapeutic opportunities.

CITÉ PAR
  1. Abolmaali Samira Sadat, Tamaddon Ali Mohammad, Dinarvand Rassoul, A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis, Cancer Chemotherapy and Pharmacology, 71, 5, 2013. Crossref

  2. Sanz Laura, Álvarez-Vallina Luis, Antibody-based antiangiogenic cancer therapy, Expert Opinion on Therapeutic Targets, 9, 6, 2005. Crossref

  3. Melkko Samu, Halin Cornelia, Borsi Laura, Zardi Luciano, Neri Dario, An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance, International Journal of Radiation Oncology*Biology*Physics, 54, 5, 2002. Crossref

  4. Wang Siao-Yi, Weiner George, Complement and cellular cytotoxicity in antibody therapy of cancer, Expert Opinion on Biological Therapy, 8, 6, 2008. Crossref

  5. Ahmadvand Davoud, Rahbarizadeh Fatemeh, Jafari Iri-Sofla Farnoush, Namazi Gholamreza, Khaleghi Sepideh, Geramizadeh Bita, Pasalar Parvin, Karimi Hosein, Aghaee Bakhtiari Seyed Hamid, Inhibition of Angiogenesis by Recombinant VEGF Receptor Fragments, Laboratory Medicine, 41, 7, 2010. Crossref

  6. Cheung Nai-Kong V., Therapeutic Antibodies and Immunologic Conjugates, in Abeloff's Clinical Oncology, 2008. Crossref

  7. Harris A.L., Angiogenesis as a new target for cancer control, European Journal of Cancer Supplements, 1, 2, 2003. Crossref

  8. Alessi Patrizia, Ebbinghaus Christina, Neri Dario, Molecular targeting of angiogenesis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1654, 1, 2004. Crossref

  9. Heinis Christian, Melkko Samu, Demartis Salvatore, Neri Dario, Two General Methods for the Isolation of Enzyme Activities by Colony Filter Screening, Chemistry & Biology, 9, 3, 2002. Crossref

  10. Heinis Christian, Huber Adrian, Demartis Salvatore, Bertschinger Julian, Melkko Samu, Lozzi Luisa, Neri Paolo, Neri Dario, Selection of catalytically active biotin ligase and trypsin mutants by phage display, Protein Engineering, Design and Selection, 14, 12, 2001. Crossref

  11. Halin Cornelia, Niesner Uwe, Villani Maria Elena, Zardi Luciano, Neri Dario, Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins, International Journal of Cancer, 102, 2, 2002. Crossref

  12. Zhu Zhenping, Hicklin Daniel J., Antibody-Mediated Drug Delivery in Cancer Therapy, in Cellular Drug Delivery, 2004. Crossref

  13. Cheung Nai-Kong V., Sondel Paul M., Immunology and Immunotherapy, in Neuroblastoma, 2005. Crossref

  14. Carter Paul, Improving the efficacy of antibody-based cancer therapies, Nature Reviews Cancer, 1, 2, 2001. Crossref

  15. Niesner Uwe, Halin Cornelia, Lozzi Luisa, Günthert Maja, Neri Paolo, Wunderli-Allenspach Heidi, Zardi Luciano, Neri Dario, Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides, Bioconjugate Chemistry, 13, 4, 2002. Crossref

  16. Ahmad Javed, Rizwanullah Md., Suthar Teeja , Albarqi Hassan A. , Ahmad Mohammad Zaki, Vuddanda Parameswara Rao , Khan Mohammad Ahmed , Jain Keerti , Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications , Critical Reviews™ in Therapeutic Drug Carrier Systems, 39, 6, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain